Abstract Background Several investigators have coupled toxins to neuropeptides for the purpose of lesioning specific neurons in the central nervous system. By producing deficits in function these toxin conjugates have yielded valuable information about the role of these cells. In an effort to specifically stimulate cells rather than kill them we have conjugated the neuropeptide substance P to the catalytic subunit of cholera toxin (SP-CTA). This conjugate should be taken up selectively by neurokinin receptor expressing neurons resulting in enhanced adenylate cyclase activity and neuronal firing. Results The conjugate SP-CTA stimulates adenylate cyclase in cultured cells that are transfected with either the NK1 or NK2 receptor, but not the N...
Aims: Neuropeptide substance P (SP) is produced and released by a subset of peripheral sensory neuro...
We hypothesized that neuropeptides released from the peripheral terminals of primary afferents play ...
The antinociceptive action of botulinum toxin type A (BoNT/A) has been demonstrated in behavioral an...
This study investigates the role of substance P and NK-1 receptors in an animal model of neuropathi...
Substance P (SP) is a prominent neuromodulator, which is produced and released by peripheral damage-...
Substance P (SP) is a highly conserved member of the tachykinin peptide family that is widely expres...
<div><p>Substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R), play important roles in...
Substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R), play important roles in transmi...
The tachykinins, substance P (SP) and neurokinin A (NKA), contained in primary afferent fibres, are...
There is an unmet medical need for the efficient treatment of neuropathic pain, a condition that aff...
In this thesis, the association between the neurokinin substance P (SP) with both its receptor (the ...
Peripheral inflammation produces pain hypersensitivity by sensitizing nociceptors. Potentiation of P...
Postsynaptic actions of substance P (SP) on mouse spinal cord neurons in primary dissociated cell cu...
International audienceTypically considered to be cell surface sensors of extracellular signals, hete...
This study examined the effects of substance P (SP) and calcitonin gene-related peptide (CGRP) on sy...
Aims: Neuropeptide substance P (SP) is produced and released by a subset of peripheral sensory neuro...
We hypothesized that neuropeptides released from the peripheral terminals of primary afferents play ...
The antinociceptive action of botulinum toxin type A (BoNT/A) has been demonstrated in behavioral an...
This study investigates the role of substance P and NK-1 receptors in an animal model of neuropathi...
Substance P (SP) is a prominent neuromodulator, which is produced and released by peripheral damage-...
Substance P (SP) is a highly conserved member of the tachykinin peptide family that is widely expres...
<div><p>Substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R), play important roles in...
Substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R), play important roles in transmi...
The tachykinins, substance P (SP) and neurokinin A (NKA), contained in primary afferent fibres, are...
There is an unmet medical need for the efficient treatment of neuropathic pain, a condition that aff...
In this thesis, the association between the neurokinin substance P (SP) with both its receptor (the ...
Peripheral inflammation produces pain hypersensitivity by sensitizing nociceptors. Potentiation of P...
Postsynaptic actions of substance P (SP) on mouse spinal cord neurons in primary dissociated cell cu...
International audienceTypically considered to be cell surface sensors of extracellular signals, hete...
This study examined the effects of substance P (SP) and calcitonin gene-related peptide (CGRP) on sy...
Aims: Neuropeptide substance P (SP) is produced and released by a subset of peripheral sensory neuro...
We hypothesized that neuropeptides released from the peripheral terminals of primary afferents play ...
The antinociceptive action of botulinum toxin type A (BoNT/A) has been demonstrated in behavioral an...